Answers are grounded in this paper and cite their sources.
Case report reveals anti-SAE antibody-positive dermatomyositis presenting as lower leg panniculitis before muscle weakness, highlighting panniculitis as an early diagnostic clue.
Myositis-specific autoantibodies found in dermatomyositis (DM) are associated with clinical symptoms and responses to therapy and are useful for diagnosis, treatment selection, and prognostication. Although the prevalence of anti-small ubiquitin-like modifier-activating enzyme (anti-SAE) antibodies in DM patients is low, clinical features such as skin symptoms preceding muscle symptoms and a higher incidence of dysphagia and malignancy have been reported. Herein, we present a case of anti-SAE antibody-positive DM in which panniculitis of the lower legs, a rare dermatological manifestation of DM, preceded muscle symptoms by 2 months. This case was associated with cervical cancer; however, the clinical course of DM was favourable with glucocorticoid monotherapy. Anti-SAE antibody-positive DM needs to be considered as a differential diagnosis of unexplained panniculitis without muscle symptoms.
No takes yet. Share an insight, caveat, or question.
Horimoto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: